1-3 of 3
Poornima Sharma
Close
Sort by
Journal Articles

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

Pamela Seam, Upendra Mahat, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Yuxia Jia, Shu Wang, Zhiheng Xu, Yvette Kasamon, Bindu Kanaparu, Nicholas Richardson, Nicole Gormley
Journal: Blood
Blood (2023) 142 (Supplement 1): 6919.
https://doi.org/10.1182/blood-2023-186544
Published: 2023
Journal Articles

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis

Upendra Mahat, Pamela Seam, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Shu Wang, Zhiheng Xu, Yuxia Jia, Nicholas Richardson, Bindu Kanapuru, Yvette Kasamon, Nicole Gormley
Journal: Blood
Blood (2023) 142 (Supplement 1): 4874.
https://doi.org/10.1182/blood-2023-182279
Published: 2023
Journal Articles

A U.S. Food and Drug Administration Age Based Pooled Analysis of Cytokine Release Syndrome and Neurotoxicity in Subjects with Relapsed/Refractory Lymphoma Treated with Chimeric Antigen Receptor (CAR) T Cell Therapy

Poornima Sharma, MD, Harpreet Singh, MD, Najat Bouchkouj, MD, Aviva C. Krauss, MD, Bindu George, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4201.
https://doi.org/10.1182/blood-2018-99-115188
Published: 2018